Targeted fetal cell‐free DNA screening for aneuploidies in 4,594 pregnancies: Single center study

BACKGROUND: Next‐generation sequencing (NGS) and discovery of fetal cell‐free DNA (cfDNA) in the maternal circulation render possible prenatal screening for trisomy 21 (Down syndrome), trisomy 18, trisomy 13, and sex chromosome aneuploidies. The approach is called “fetal cfDNA screening” and in cont...

Descripción completa

Detalles Bibliográficos
Autores principales: Koc, Altug, Ozer Kaya, Ozge, Ozyilmaz, Berk, Kutbay, Yasar B., Kirbiyik, Ozgur, Ozdemir, Taha R., Erdogan, Kadri M., Saka Guvenc, Merve, Oztekin, Deniz C., Ozeren, Mehmet, Pala, Halil G., Ekin, Atalay, Gezer, Cenk, Sahingoz Yildirim, Alkim G., Konuralp Atakul, Bahar, Kurtulmus, Secil, Turhan, Ugur, Taner, Cuneyt E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6625369/
https://www.ncbi.nlm.nih.gov/pubmed/31070015
http://dx.doi.org/10.1002/mgg3.678

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6625369/
https://www.ncbi.nlm.nih.gov/pubmed/31070015
http://dx.doi.org/10.1002/mgg3.678

Ejemplares similares